Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, February 3, 2021
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
[ Wed, Feb 03rd 2021
] - WOPRAI
Thomas Shrader Downgraded (VYGR) to Hold on, Feb 3rd, 2021
Thomas Shrader of BTIG, Downgraded "Voyager Therapeutics, Inc." (VYGR) to Hold on, Feb 3rd, 2021.
Thomas has made no other calls on VYGR in the last 4 months.
There are 2 other peers that have a rating on VYGR. Out of the 2 peers that are also analyzing VYGR, 1 agrees with Thomas's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jay Olson of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, November 11th, 2020
This is the rating of the analyst that currently disagrees with Thomas
- Reni Benjamin of "Raymond James" Downgraded from Strong Buy to Buy and Decreased Target to $17 on, Tuesday, November 10th, 2020
